Acerca de
Nuestra Labor
Datos y herramientas
Eventos
Noticias

EVENTOS

Logo de CCS 2025

La Cumbre 2025 de la FMH sobre atención integral: Nuevos avances en trastornos de la coagulación y temas musculoesqueléticos (MSK), se celebrará del 23 al 25 de abril de 2025 en Dubai. Esta cumbre está abierta internacionalmente a todos los participantes.

Foro Mundial de la FMH

El 13o Foro Mundial de la FMH tendrá lugar en persona, del 17 al 18 de noviembre de 2023, en la hermosa ciudad de Montreal, Canadá.

Cumbre mundial de la FMH sobre mujeres y niñas con trastornos de la coagulación

La tercera Cumbre mundial de la FMH sobre mujeres y niñas con trastornos de la coagulación (MNTC) se llevará a cabo de manera virtual los días 28 y 29 de septiembre de 2023, de 9:00 a. m. a 2:00 p. m. (EDT).

Cumbre 2023 de la FMH sobre atención integral

La Cumbre mundial abarcará el congreso internacional bienal de la FMH sobre temas musculoesqueléticos (MSK) e incluirá segmentos multidisciplinarios, médicos y sobre temas MSK, todos centrados en torno a personas con trastornos de la coagulación.

Sommet mondial de la FMH sur les politiques et l’accès aux traitements

La segunda edición de la Cumbre mundial de la FMH sobre políticas y acceso a tratamiento tendrá lugar los días 27 y 28 de octubre de 2022.

Cumbre 2023 de la FMH sobre atención integral
 

La Cumbre 2023 de la FMH sobre atención integral: Nuevos avances en trastornos de la coagulación y temas musculoesqueléticos (MSK) tendrá lugar del 10 al 12 de mayo de 2023, en Buenos Aires, Argentina.

CALENDARIO DE EVENTOS

NOTICIAS SOBRE EVENTOS

< PREV NEXT >

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.